MeRIP sequencing in a transgenic mouse model of breast cancer

The m6A RNA methylation is emerging as a significant factor in breast cancer pathology, yet the specific correlations and underlying mechanisms remain unclear. This study explores these aspects in depth.We employed MeRIP-seq to analyze the m6A methylation in a transgenic mouse model of breast cancer to explore the reversibility of m6A methylation and provide a deeper understanding of the intricate mechanisms driving breast cancer development and potential therapeutic targets.